Jan‐Niclas Mumm
Papers
1
Total Citations
2
H-Index
1
About
Jan-Niclas Mumm is a clinical researcher whose work focuses on the intersection of radiation oncology and urologic oncology, particularly the application of advanced stereotactic techniques in the management of renal cell carcinoma (RCC). His major contributions center on evaluating the safety and efficacy of robotic radiosurgery (RRS) as a non-invasive, ablative treatment for visceral and lymph node metastases of RCC—a patient population often facing complex clinical decisions amid evolving systemic therapies. In his most cited work, a retrospective single-center analysis from 2021, Mumm demonstrated that RRS offers a promising local control option with a favorable safety profile, helping to define its role in oligometastatic disease management. While his citation count is still growing, this foundational study has been cited twice and contributes to the emerging evidence base for metastasis-directed therapy in RCC. Mumm’s research is particularly valuable for clinicians and researchers seeking to integrate precision radiotherapy into multidisciplinary cancer care, highlighting his commitment to improving outcomes for patients with advanced kidney cancer through innovative, minimally invasive approaches.
Research Focus
Key Achievements
Top Papers
- 1